Introduction: Neonatal Abstinence Syndrome (NAS) is a condition in newborns characterized by withdrawal symptoms due to in-utero exposure to certain substances, primarily opioids. This syndrome is increasingly common due to the rise in opioid use and addiction among pregnant women. Managing Neonatal Abstinence Syndrome (NAS) involves a combination of pharmacological and non-pharmacological strategies to alleviate withdrawal symptoms and support the infant’s overall health and development.   Causes of Neonatal Abstinence Syndrome Neonatal Abstinence Syndrome (NAS) primarily results from prenatal exposure to opioids, but it can also be caused by other substances. Understanding the causes is crucial for prevention and management.…